US To Produce 100 Million Doses Of COVID-19 Investigational Vaccine

US To Produce 100 Million Doses Of COVID-19 Investigational Vaccine

Eurasia Review

Published

The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) announced on Tuesday an agreement with Moderna, Inc. to manufacture and deliver 100 million doses of the company’s COVID-19 vaccine candidate. The federal government will own these vaccine doses.

The vaccine, called mRNA-1273, has been...

Full Article